@article{b743f541620d4276bdf98172d80ad9a4,
title = "ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder",
abstract = "ZMYND11 is the critical gene in chromosome 10p15.3 microdeletion syndrome, a syndromic cause of intellectual disability. The phenotype of ZMYND11 variants has recently been extended to autism and seizures. We expand on the epilepsy phenotype of 20 individuals with pathogenic variants in ZMYND11. We obtained clinical descriptions of 16 new and nine published individuals, plus detailed case history of two children. New individuals were identified through GeneMatcher, ClinVar and the European Network for Therapies in Rare Epilepsy (NETRE). Genetic evaluation was performed using gene panels or exome sequencing; variants were classified using American College of Medical Genetics (ACMG) criteria. Individuals with ZMYND11 associated epilepsy fell into three groups: (i) atypical benign partial epilepsy or idiopathic focal epilepsy (n = 8); (ii) generalised epilepsies/infantile epileptic encephalopathy (n = 4); (iii) unclassified (n = 8). Seizure prognosis ranged from spontaneous remission to drug resistant. Neurodevelopmental deficits were invariable. Dysmorphic features were variable. Variants were distributed across the gene and mostly de novo with no precise genotype–phenotype correlation. ZMYND11 is one of a small group of chromatin reader genes associated in the pathogenesis of epilepsy, and specifically ABPE. More detailed epilepsy descriptions of larger cohorts and functional studies might reveal genotype–phenotype correlation. The epileptogenic mechanism may be linked to interaction with histone H3.3.",
keywords = "antiepileptic drug, autism, bromodomain, comorbidity, EEG, epigenetic, histone H3.3, seizure",
author = "Stephanie Oates and Michael Absoud and Sushma Goyal and Sophie Bayley and Jennifer Baulcomb and Annemarie Sims and Amy Riddett and Katrina Allis and Charlotte Brasch-Andersen and Meena Balasubramanian and Renkui Bai and Bert Callewaert and Ulrike H{\"u}ffmeier and {Le Duc}, Diana and Maximilian Radtke and Christian Korff and Joanna Kennedy and Karen Low and M{\o}ller, {Rikke S.} and Nielsen, {Jens Erik Klint} and Bernt Popp and Lina Quteineh and Gitte R{\o}nde and Bitten Sch{\"o}newolf-Greulich and Amelle Shillington and Taylor, {Matthew R.G.} and Emily Todd and Torring, {Pernille M.} and DMSc, {Zeynep T{\"u}mer M.D.Ph D.} and Georgia Vasileiou and Yates, {T. Michael} and Christiane Zweier and Richard Rosch and Basson, {M. Albert} and Pal, {Deb K.}",
note = "Funding Information: This work was supported by grants from the European Union Programme of the Seventh Framework: Development of Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy, “DESIRE” (602531, DKP); Canadian Institutes of Health Research: Biology of Juvenile Myoclonic Epilepsy (BIOJUME) (201503MOP‐342469, DKP); National Institute for Health Research Programme Grant for Applied Research: Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) RP‐PG‐0615‐20007 (DKP); Waterloo Foundation Project Grant 164‐3020 (DKP); Charles Sykes Epilepsy Research Trust (DKP); NIHR Specialist Biomedical Research Centre for Mental Health of South London and Maudsley NHS Foundation Trust (DKP). Funding Information: This work was supported by grants from the European Union Programme of the Seventh Framework: Development of Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy, ?DESIRE? (602531, DKP); Canadian Institutes of Health Research: Biology of Juvenile Myoclonic Epilepsy (BIOJUME) (201503MOP-342469, DKP); National Institute for Health Research Programme Grant for Applied Research: Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) RP-PG-0615-20007 (DKP); Waterloo Foundation Project Grant 164-3020 (DKP); Charles Sykes Epilepsy Research Trust (DKP); NIHR Specialist Biomedical Research Centre for Mental Health of South London and Maudsley NHS Foundation Trust (DKP). Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = oct,
doi = "10.1111/cge.14023",
language = "English",
volume = "100",
pages = "412--429",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "4",
}